
Tanacetum parthenium, better known as feverfew, is a small daisy-like plant that has been used for centuries for headaches, fevers, and inflammatory conditions. Today it is best known as a herbal option for people who experience recurrent migraine attacks and are looking for non-drug support. The plant’s leaves and flowering tops contain sesquiterpene lactones such as parthenolide, along with flavonoids and volatile oils that appear to influence inflammation, blood vessel tone, and platelet activity. Modern extracts are usually standardized to specific parthenolide levels to improve consistency.
This guide walks you through how Tanacetum parthenium appears to work, the main benefits that have been studied, and realistic expectations about what it can and cannot do. You will also find practical dosage ranges, how to use different product forms, how to avoid common mistakes, and the key safety issues, including who should not take it and when to stop before surgery.
Key Insights for Tanacetum parthenium
- Tanacetum parthenium is most often used to help prevent recurrent migraines rather than to stop individual attacks.
- Standardized preparations typically provide around 50–150 mg of dried leaf daily, often with 0.2–0.5% parthenolide.
- Common side effects include mouth irritation with fresh leaves and mild digestive upset with oral products.
- People who are pregnant, planning surgery, or allergic to plants in the daisy family should generally avoid feverfew.
- Any long term use for migraine prevention should be supervised by a qualified health professional.
Table of Contents
- What is Tanacetum parthenium and how does it work?
- Main benefits people seek from Tanacetum parthenium
- How to take Tanacetum parthenium in practice
- Choosing quality Tanacetum parthenium products
- Side effects, interactions, and who should avoid it
- What the scientific evidence says overall
What is Tanacetum parthenium and how does it work?
Tanacetum parthenium is a perennial herb in the Asteraceae (daisy) family. It grows up to about one meter tall, with pale yellow-green, aromatic leaves and small white flowers that resemble miniature daisies. Traditionally, herbalists have used feverfew for fevers, arthritis, digestive upset, and menstrual discomfort. In modern practice, the focus has shifted to migraine prevention and anti-inflammatory effects.
The main parts used medicinally are the leaves and sometimes the flowering tops. These plant tissues contain a complex mixture of natural compounds. The best studied group is the sesquiterpene lactones, particularly parthenolide, which is considered a key active constituent. Parthenolide is concentrated in the superficial glands on the leaves, not in the stems. This detail matters because products that use the right part of the plant and handle it correctly can deliver more consistent amounts.
On a biochemical level, extracts of Tanacetum parthenium appear to influence several pathways related to inflammation and vascular function. In cell and animal studies, feverfew components have been shown to:
- Reduce the release of pro-inflammatory substances such as prostaglandins and certain cytokines
- Inhibit activation of the NF-kappaB pathway, a central regulator of inflammatory gene expression
- Modulate platelet behavior, including serotonin release and aggregation
- Relax smooth muscle in blood vessel walls, which can influence vessel constriction and dilation
Because migraine involves abnormal blood vessel tone, inflammation, and nerve sensitivity, these effects help explain why feverfew has been studied as a preventive option. There is also early experimental work on antioxidant and potential anticancer activity, but these uses remain exploratory and are not standard clinical indications.
Importantly, different preparations can vary greatly in parthenolide content. Fresh leaves, dried leaves, teas, tinctures, and standardized extracts all deliver different profiles of active compounds. Storage conditions, harvest time, and seed origin can also change parthenolide levels. For this reason, many modern products are standardized to contain a defined percentage of parthenolide, often around 0.2–0.5%, to provide somewhat predictable dosing.
Main benefits people seek from Tanacetum parthenium
Most people consider Tanacetum parthenium for one central reason: to reduce the frequency or severity of migraines. In clinical trials, feverfew has been used as a preventive supplement, taken daily for weeks to months. Results have been mixed, but several studies and reviews suggest that standardized feverfew products can modestly reduce migraine attack frequency in some individuals, especially when used consistently.
The typical pattern seen in research is a small reduction in the number of monthly attacks compared with placebo, sometimes along with decreased intensity, nausea, or sensitivity to light and sound. Feverfew is not a fast-acting painkiller. It is not used to stop a migraine once it has started. Instead, the goal is to make attacks less common over time. For some people this translates into fewer missed days of work or school, and a reduced need for acute medications.
Beyond migraine, feverfew has a long history of use for general headaches and tension-type pain. Evidence for these uses is weaker, but some people report that their non-migraine headaches occur less often when they use feverfew regularly. Because the herb influences inflammatory mediators and blood vessel tone, these anecdotal benefits are biologically plausible, though not as well documented as migraine prophylaxis.
Another area of interest is joint and inflammatory conditions. Traditional use includes arthritis and rheumatic pain. Laboratory studies show that parthenolide and related compounds can reduce inflammatory signals in joint tissues and inhibit factors involved in cartilage damage. A small clinical trial in rheumatoid arthritis found limited benefit, with improved grip strength but no robust, broad effect on symptoms. At present, feverfew should not be considered a primary treatment for inflammatory arthritis, but it may be of interest as part of a broader anti-inflammatory strategy under professional guidance.
Topical formulations of parthenolide-depleted feverfew extracts are used in some cosmetic and dermatologic products. These are designed to provide antioxidant and soothing effects while minimizing the risk of skin reactions linked to parthenolide. Small studies suggest potential benefit for sensitive, redness-prone skin, though these are cosmetic rather than therapeutic claims.
A final point is overall well-being. Some people report improved sense of control over their migraines and reduced reliance on acute medications when feverfew works for them. However, responses are individualized. Many users do not experience dramatic benefits, and some notice no clear effect at all, even after several months.
How to take Tanacetum parthenium in practice
There are several ways to use Tanacetum parthenium, and the choice of form affects both effectiveness and side-effect risk. The most common modern options are standardized capsules or tablets, traditional dried leaf capsules, tinctures, teas, and, less frequently, fresh leaves.
Standardized extract products are usually preferred for migraine prevention because they provide more consistent amounts of key constituents. Many commercial preparations are standardized to contain approximately 0.2–0.5% parthenolide. Typical daily doses in migraine studies have ranged from the equivalent of about 50–150 mg of dried leaf material, often taken once daily or divided into two or three doses depending on the product labeling.
For non-standardized dried leaf capsules, daily amounts in the same range (50–150 mg dried leaf) have been used for several months at a time in clinical contexts. Because batch-to-batch variation can be large, following the manufacturer’s guidance and, ideally, choosing a product that documents parthenolide content is important.
Some traditional use involves chewing fresh feverfew leaves, usually one to three leaves per day. This method delivers high local exposure in the mouth and can lead to mouth ulcers, irritation, numbness, and taste disturbances. Because of this, fresh leaf chewing is now generally discouraged in favor of encapsulated or processed forms, which tend to be better tolerated.
Tea and tinctures are less common for migraine prevention because it is difficult to know how much parthenolide is present in a given cup or dropperful. Parthenolide stability is influenced by pH, temperature, and storage conditions, so a home-brewed tea from dried herb cannot be assumed to reproduce the doses used in studies. If teas or tinctures are used, they should be considered adjunctive and not directly comparable to standardized capsule dosing.
Time course is also important. Feverfew is not expected to help after a single dose. Many protocols suggest taking it daily for at least 4–6 weeks before judging the effect, and it may take 2–3 months to see a stable pattern. Because abrupt discontinuation has occasionally been linked to rebound headaches or increased migraine frequency, any decision to stop long-term use is best done gradually over several weeks.
In all cases, coordination with a clinician who understands both migraine management and herbal medicine is ideal. They can help integrate feverfew with prescribed preventive drugs, acute migraine treatments, and lifestyle strategies such as sleep regularity, hydration, and trigger management.
Choosing quality Tanacetum parthenium products
Selecting a high-quality Tanacetum parthenium supplement makes a practical difference because content and purity can vary between brands. Herbal products are often regulated as dietary supplements rather than drugs, which means manufacturers are responsible for quality but not required to prove efficacy before selling their products.
A good starting point is to look for products that clearly state the plant name and part used (for example, “Tanacetum parthenium leaf” or “feverfew aerial parts”). The label should specify the amount per capsule or tablet in milligrams and, ideally, the parthenolide content or a standardization range, such as “standardized to 0.2% parthenolide.” This helps you compare products and align with dosage ranges used in clinical trials and monographs.
Third-party testing is another useful indicator. Some manufacturers have their products tested by independent organizations for identity, potency, and contaminants such as heavy metals, pesticides, and microbes. Seals or statements about such testing on the label or company website can add confidence, though they are not a guarantee of effectiveness.
The choice between capsules, tablets, and liquid extracts is mostly about convenience and tolerance. Capsules and coated tablets are easier on the mouth and taste buds than raw herb. If you are sensitive to digestive upset, starting with a lower dose or taking the product with food may be helpful. Avoid combination products that mix feverfew with many other herbs unless there is a specific plan for each ingredient and you understand the overall interaction profile.
Storage also matters. Parthenolide can degrade with heat, humidity, and prolonged storage. Store feverfew products in a cool, dry place away from direct sunlight. Avoid using products past their expiration date, and be cautious about bulk powders of uncertain age and origin.
If you are considering topical products (such as creams with parthenolide-depleted feverfew extract) for sensitive or redness-prone skin, patch-test a small area first. Even parthenolide-reduced extracts can sometimes cause irritation, especially in people with allergies to other members of the daisy family.
Finally, be alert to marketing claims that sound exaggerated, such as promises to “cure migraines” or to act as a comprehensive anti-cancer remedy. Responsible manufacturers typically describe their products as supportive or preventive, not as stand-alone cures for complex conditions.
Side effects, interactions, and who should avoid it
Even though Tanacetum parthenium is widely used and generally well tolerated in adults, it is not risk-free. Understanding common side effects and clear contraindications is essential before starting any long-term regimen.
The most frequent adverse effects involve the mouth and digestive tract. Chewing fresh feverfew leaves can cause burning, tingling, swelling of the lips and tongue, and painful mouth ulcers. Encapsulated dried leaf or standardized extracts reduce contact with oral tissues and therefore reduce this particular problem, but occasional reports of altered taste or mild mouth irritation still occur.
Gastrointestinal side effects can include nausea, abdominal discomfort, indigestion, diarrhea, constipation, or bloating. These symptoms are often dose-related and may improve when the dose is reduced or taken with food. If significant digestive issues persist, stopping the product and seeking medical advice is appropriate.
Allergic reactions are an important concern. Because feverfew belongs to the Asteraceae family, people who are allergic to ragweed, chamomile, chrysanthemum, marigold, or related plants may be more likely to react. Reactions can range from mild skin rashes and contact dermatitis to more pronounced respiratory or systemic symptoms. Anyone with a known serious allergy to this plant family should avoid feverfew.
Feverfew can influence blood clotting, likely through effects on platelet function. As a result, it may increase bleeding risk, especially when combined with other agents that affect clotting, such as anticoagulant or antiplatelet medications, nonsteroidal anti-inflammatory drugs, and some herbal products like ginkgo or garlic. Standard guidance is to stop feverfew at least two weeks before planned surgery or invasive dental procedures to reduce the risk of excessive bleeding.
Certain groups are generally advised not to use feverfew at all. These include:
- Pregnant individuals, because feverfew may affect uterine contractions and has historically been used for its emmenagogue effects
- People who are breastfeeding, due to limited data on excretion into breast milk and effects on infants
- Children, particularly young children, because robust safety studies are lacking
- Individuals with bleeding disorders or those with a history of easy bruising
- Anyone with a prior severe reaction to feverfew or similar herbs
Another subtle issue is discontinuation. Some people who have been taking feverfew daily for months and then stop abruptly report increased headaches, anxiety, insomnia, or muscle tension. This pattern, sometimes called “post-feverfew syndrome,” reinforces the idea that if you decide to stop long-term use, tapering the dose gradually may be more comfortable than stopping overnight.
As with any supplement, feverfew should be added to a medication list shared with all your health-care providers. They can help identify potential interactions with migraine drugs, anticoagulants, blood-pressure medications, or other therapies, and can help you weigh the risks and benefits in the context of your overall health.
What the scientific evidence says overall
The evidence base for Tanacetum parthenium is moderate in size and mixed in its conclusions. It is stronger for migraine prevention than for other uses, but even in this area, results are not uniform. Understanding the overall pattern can help set realistic expectations.
A number of randomized, placebo-controlled trials have examined standardized feverfew preparations for migraine prophylaxis. These studies have used different types of extracts, varied parthenolide content, and dosing schedules ranging from several weeks to a few months. Some trials show a modest but statistically significant reduction in the number of monthly attacks, while others show little or no clear benefit. When data are pooled in systematic reviews, feverfew often emerges as “possibly helpful” for migraine prevention, with small effect sizes and a call for more consistent, higher-quality research.
Reasons for the variability likely include differences in plant material, manufacturing processes, and standardization, as well as small sample sizes and differences in how outcomes are measured. For example, a preparation with low parthenolide content may not perform the same as one with a higher standardized level, even if labeled simply “feverfew.” This makes it difficult to generalize results from one product to all others on the market.
For other indications such as rheumatoid arthritis, inflammatory skin conditions, or general pain, the evidence is thinner. A few small trials and experimental studies suggest potential anti-inflammatory effects, but these have not yet translated into strong, guideline-level recommendations. Topical parthenolide-depleted extracts are supported mainly by small dermatologic studies and cosmetic claims rather than large clinical trials.
On the safety side, observational data and monograph reviews agree that feverfew is usually well tolerated when used orally for several months in typical doses. Serious adverse events are rare, but mouth ulceration, gastrointestinal upset, and allergic reactions are well documented. Concerns about pregnancy, lactation, and bleeding risk are based on mechanistic reasoning, case reports, and precautionary principles rather than extensive controlled trials, but they are taken seriously in clinical practice.
Major professional and governmental bodies tend to describe feverfew as a complementary option for adults with diagnosed migraine who are interested in herbal prevention. They emphasize that it should not replace a full evaluation for secondary causes of headache and that people should continue to use conventional therapies when indicated. Feverfew may be one part of a comprehensive plan that includes prescription preventives, acute migraine medications, lifestyle adjustments, and trigger management.
In summary, the scientific picture supports Tanacetum parthenium as a potentially helpful, but not universally effective, adjunct for migraine prevention in selected adults. Evidence for other uses remains preliminary. Because product quality and individual response vary, careful selection of standardized products, realistic expectations, and medical supervision are essential.
References
- Feverfew: Usefulness and Safety | NCCIH 2025 (Guideline)
- Feverfew – Drugs and Lactation Database (LactMed®) – NCBI Bookshelf 2022 (Guideline)
- Assessment report on Tanacetum parthenium (L.) Schultz Bip., herba 2019 (Guideline)
- NATURAL HEALTH PRODUCT FEVERFEW – TANACETUM PARTHENIUM 2007 (Guideline)
- Feverfew Uses, Benefits & Dosage 2025 (Monograph)
Disclaimer
The information in this article is for general educational purposes only and is not a substitute for personal medical advice, diagnosis, or treatment. Tanacetum parthenium (feverfew) can interact with medications and may not be safe for everyone, including people who are pregnant, breastfeeding, have bleeding disorders, significant medical conditions, or take prescription or over-the-counter drugs. Never start, stop, or change any treatment, including herbal supplements, without discussing it with a qualified health-care professional who knows your medical history. If you experience new or worsening symptoms while using feverfew, seek medical attention promptly.
If you found this guide helpful, please consider sharing it on Facebook, X (formerly Twitter), or any social platform you prefer, and follow our work on social media. Your support in sharing our articles helps our team continue to research and produce reliable, in-depth health content for readers around the world.





